Navigate Titan Pharmaceuticals, Inc.
Home
About
Overview
Who We Are
IP Portfolio
Management Team
Board of Directors
Careers
Technology
Pipeline
Kappa Opioid Receptor Agonist
Nalmefene Implant
News
Overview
Press Releases
Events
Presentations
In the News
Publications
Posters
Media Resources
Investors
Overview
News / Events
Company Information
Stock Data
SEC Filings
Corporate Governance
Contact
Search
All SEC Filings
Home
Investors
SEC Filings
All SEC Filings
Investors
Navigate Investors
Overview
News / Events
Company Information
Stock Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Email Alerts
Tear Sheet
Contacts
RSS News Feed
All SEC Filings
Filter Filings:
View All
10-12G
10-12G/A
10-K
10-K/A
10-K405
10-Q
10-Q/A
10KSB40
10QSB
15-12B
25
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
8-A12B
8-A12B/A
8-A12G
8-K
8-K/A
ARS
AW
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFN14A
DEFR14A
DFAN14A
EFFECT
FWP
NT 10-Q
POS AM
PRE 14A
PREN14A
PRRN14A
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Date
Form
Description
Docs
XBRL
Pages
05/12/08
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Related Documents
EX-31.1
EX-31.2
EX-32
19
05/02/08
DEFR14A
Definitive revised proxy soliciting materials
44
04/30/08
8-K
Current report filing
Related Documents
EX-10.1
EX-99.1
12
04/03/08
DEF 14A
Definitive proxy statements
44
03/31/08
10-K/A
Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-21
EX-23.1
EX-31.1
EX-31.2
EX-32
79
03/26/08
S-8
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Related Documents
EX-4.2
EX-5.1
EX-23.1
14
03/14/08
PRE 14A
Preliminary proxy statement not related to a contested matter or merger/acquisition
42
03/12/08
10-K
Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-10.46
EX-10.47
EX-21
EX-23.1
EX-31.1
EX-31.2
EX-32
85
03/10/08
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
6
02/14/08
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
<< Previous
1...
63
64
65
66
67
68
69
70
71
72
...101
Next >>